Most recently, enhanced expression of TAZ has been found in many malignant tumors, including gastric cancer, oral cancer, non-small cell lung cancer (NSCLC), breast cancer and neuroblastoma [11–14]. This evidence concerns the gene WWTR1 and lip and oral cavity carcinoma.